1. Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis
- Author
-
Mackenzie K. Herroon, Yu Wang, Russell S. Taichman, Steven P. Zielske, Frank C. Cackowski, Leigh Ellis, and Izabela Podgorski
- Subjects
Androgen Receptor Positive ,Diseases of the musculoskeletal system ,Metastasis ,Prostate cancer ,Model system ,Osteoclast ,medicine ,Immune competent ,Bone ,RC254-282 ,business.industry ,Bone metastasis ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Androgen receptor ,medicine.anatomical_structure ,Oncology ,RC925-935 ,Cancer cell ,Cancer research ,Bone marrow ,business ,Research Paper - Abstract
Highlights • Mouse prostate cancer Myc-CaP cells readily form bone tumors in FVB/NJ mice. • Tumors are grossly confined to bone after intraosseous injection. • Myc-CaP bone tumors have a mixed osteolytic/osteosclerotic morphology. • Syngeneic Myc-CaP tumors model key aspects of prostate cancer bone metastases., Prostate cancer (PCa) metastasis research has been hamstrung by lack of animal models that closely resemble the disease present in most patients – that metastasize to bone, are dependent on the androgen receptor (AR), and grow in an immune competent host. Here, we adapt the Myc-CaP cell line for use as a PCa androgen dependent, immune competent bone metastases model and characterize the metastases. After injection into the left cardiac ventricle of syngeneic FVB/NJ mice, these cells formed bone metastases in the majority of animals; easily visible on H&E sections and confirmed by immunohistochemistry for Ar and epithelial cell adhesion molecule. Mediastinal tumors were also observed. We also labeled Myc-CaP cells with tdTomato, and confirmed the presence of cancer cells in bone by flow cytometry. To adapt the model to a bone predominant metastasis pattern and further examine the bone phenotype, we labeled the cells with luciferase, injected in the tibia and observed tumor formation only in tibia with a mixed osteolytic/osteoblastic phenotype. The presence of Myc-CaP tumors significantly increased tibia bone volume as compared to sham injected controls. The osteoclast marker, TRAcP-5b was not significantly changed in plasma from tibial tumor bearing animals vs. sham animals. However, conditioned media from Myc-CaP cells stimulated osteoclast formation in vitro from FVB/NJ mouse bone marrow. Overall, Myc-CaP cells injected in the left ventricle or tibia of syngeneic mice recapitulate key aspects of human metastatic PCa. more...
- Published
- 2021